• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

In-vitro selection of bacteria resistant to the 4-quinolone agents.

作者信息

Limb D I, Dabbs D J, Spencer R C

出版信息

J Antimicrob Chemother. 1987 Jan;19(1):65-71. doi: 10.1093/jac/19.1.65.

DOI:10.1093/jac/19.1.65
PMID:3470281
Abstract

The activity of five 4-quinolone agents: norfloxacin, ciprofloxacin, ofloxacin, enoxacin and pefloxacin was tested against 121 distinct clinical bacterial isolates. Ciprofloxacin was the most active agent against Gram-negative bacteria and streptococci and pefloxacin was the most active against staphylococci. By serial sub-culture in sub-inhibitory concentrations of antibiotic we were able to select resistance in almost all Gram-positive and Gram-negative species, with the exception of Escherichia coli. Resistance to norfloxacin was more readily produced than resistance to the other four agents. There was almost complete cross-resistance among the five agents tested. The proportional increases in MIC were higher in Gram-negative than in Gram-positive organisms.

摘要

相似文献

1
In-vitro selection of bacteria resistant to the 4-quinolone agents.
J Antimicrob Chemother. 1987 Jan;19(1):65-71. doi: 10.1093/jac/19.1.65.
2
Comparative in vitro activities of pefloxacin, ofloxacin, enoxacin and ciprofloxacin against 256 clinical isolates.培氟沙星、氧氟沙星、依诺沙星和环丙沙星对256株临床分离株的体外活性比较
Acta Pathol Microbiol Immunol Scand B. 1987 Apr;95(2):141-6. doi: 10.1111/j.1699-0463.1987.tb03102.x.
3
In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.需氧革兰氏阴性血培养分离株对恶喹酸、诺氟沙星、环丙沙星、依诺沙星、培氟沙星、氧氟沙星和氧恶喹酸的体外敏感性
Infection. 1986 May-Jun;14(3):142-4. doi: 10.1007/BF01643481.
4
[In vitro activity of new quinolones against nonfermenters and references to sensitivity tests].新型喹诺酮类药物对非发酵菌的体外活性及敏感性试验参考
Infection. 1986;14 Suppl 3:S191-5. doi: 10.1007/BF01667842.
5
Ofloxacin: antibacterial activity, induction of resistance and killing curves.氧氟沙星:抗菌活性、耐药性诱导及杀菌曲线
Chemioterapia. 1985 Aug;4(4):278-83.
6
Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
J Antimicrob Chemother. 1987 Sep;20(3):363-72. doi: 10.1093/jac/20.3.363.
7
The comparative in-vitro activity of eight newer quinolones and nalidixic acid.八种新型喹诺酮类药物与萘啶酸的体外活性比较
J Antimicrob Chemother. 1986 Nov;18 Suppl D:1-20. doi: 10.1093/jac/18.supplement_d.1.
8
In-vitro activity of newer quinolones against aerobic bacteria.新型喹诺酮类药物对需氧菌的体外活性
J Antimicrob Chemother. 1986 Apr;17 Suppl B:29-39. doi: 10.1093/jac/17.suppl_b.29.
9
Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.环丙沙星、依诺沙星、诺氟沙星、氧氟沙星和培氟沙星对脆弱拟杆菌和艰难梭菌的体外活性比较
Scand J Infect Dis. 1986;18(2):149-51. doi: 10.3109/00365548609032321.
10
[In vitro activity of new quinolones against Mycoplasma pathogenic to humans].新型喹诺酮类药物对人致病性支原体的体外活性
Pathol Biol (Paris). 1988 May;36(5):496-9.

引用本文的文献

1
Discovery and development of new antibiotics: the problem of antibiotic resistance.新型抗生素的发现与研发:抗生素耐药性问题
Antimicrob Agents Chemother. 1993 Mar;37(3):377-83. doi: 10.1128/AAC.37.3.377.
2
Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations.结核分枝杆菌gyrA和gyrB基因的克隆、核苷酸序列测定及喹诺酮耐药性突变检测
Antimicrob Agents Chemother. 1994 Apr;38(4):773-80. doi: 10.1128/AAC.38.4.773.
3
Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus.
金黄色葡萄球菌逐步筛选的环丙沙星耐药突变体中gyrA和grlA突变的分析
Antimicrob Agents Chemother. 1995 Jul;39(7):1554-8. doi: 10.1128/AAC.39.7.1554.
4
Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin.在引入诺氟沙星和氧氟沙星后对萘啶酸和氟喹诺酮类药物耐药性的发展。
Antimicrob Agents Chemother. 1988 Aug;32(8):1285-8. doi: 10.1128/AAC.32.8.1285.
5
Antagonism of wild-type and resistant Escherichia coli and its DNA gyrase by the tricyclic 4-quinolone analogs ofloxacin and S-25930 stereoisomers.三环4-喹诺酮类似物氧氟沙星和S-25930立体异构体对野生型和耐药型大肠杆菌及其DNA促旋酶的拮抗作用。
Antimicrob Agents Chemother. 1987 Nov;31(11):1861-3. doi: 10.1128/AAC.31.11.1861.
6
In-vitro activity of lomefloxacin (SC-47111) and other quinolones.洛美沙星(SC - 47111)及其他喹诺酮类药物的体外活性。
Infection. 1989 May-Jun;17(3):165-7. doi: 10.1007/BF01644019.
7
Increasing rates of in vitro resistance to ciprofloxacin and norfloxacin in isolates from urine specimens.尿液标本分离株对环丙沙星和诺氟沙星的体外耐药率不断上升。
Antimicrob Agents Chemother. 1989 Apr;33(4):595-6. doi: 10.1128/AAC.33.4.595-b.
8
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
9
Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.培氟沙星。对其抗菌活性、药代动力学特性及治疗用途的综述。
Drugs. 1989 May;37(5):628-68. doi: 10.2165/00003495-198937050-00003.
10
Studies on the emergence of resistance to lomefloxacin in vitro.
Eur J Clin Microbiol Infect Dis. 1989 Aug;8(8):741-5. doi: 10.1007/BF01963766.